Petrovski Stefan, Karakolevska-Ilova Marija, Simeonovska-Joveva Elena, Serafimov Aleksandar, Adzi-Andov Ljubica, Dimitrova Violeta
Clinical Hospital Shtip, Surgery, Ljuben Ivanov bb, Shtip, Republic of Macedonia.
Clinical Hospital Shtip, Oncology, Shtip, Republic of Macedonia.
Open Access Maced J Med Sci. 2018 Jun 9;6(6):1046-1051. doi: 10.3889/oamjms.2018.116. eCollection 2018 Jun 20.
Colorectal liver metastases have a poor prognosis, and only 2% have an average 5-year survival if left untreated. Despite radical resection, the average five-year survival is between 25% and 44%.
To explore the experience of the Clinic in the treatment of colorectal liver metastases, comparing it with data from the literature and based on the comparison to determine the influence of the type and extensity of resection survival after radical surgical treatment of patients.
This is a retrospective study. The study comprised the period between 01.01.2006 to 31.12.2015. It included a total of 239 cases, of whom: 179 patients underwent radical interventions, 5 palliative and 55 patients underwent explorative interventions due to liver metastases.
Radical resection of liver metastases has the impact of the patient survival, and the survival is the smallest in the patients with left hemihepatectomy and the longest in the patients with bisegmentectomy. But no specific technique and the number of resected segments influenced the survival of patients with colorectal liver metastases.
In patients with colorectal liver metastases only resection has potentially curative character. The type and amount of liver resection has no influence of the survival.
结直肠癌肝转移预后较差，若不治疗，仅有2%的患者平均5年生存率。尽管进行了根治性切除，平均5年生存率仍在25%至44%之间。
探讨本诊所治疗结直肠癌肝转移的经验，与文献数据进行比较，并基于比较结果确定根治性手术治疗后切除类型和范围对患者生存的影响。
这是一项回顾性研究。研究涵盖2006年1月1日至2015年12月31日期间。共纳入239例病例，其中：179例患者接受了根治性干预，5例接受姑息性治疗，55例因肝转移接受探查性干预。
肝转移瘤的根治性切除对患者生存有影响，左半肝切除患者的生存率最低，双段切除患者的生存率最长。但没有特定技术和切除段数影响结直肠癌肝转移患者的生存。
对于结直肠癌肝转移患者，只有切除具有潜在治愈性。肝切除的类型和范围对生存无影响。
